3M reported solid Q4 results that met expectations and slightly raised their 2010 guidance, highlighting strong performances in key segments like healthcare and consumer office. Management expressed cautious optimism with continued investments in R&D and strategic growth in international markets, which should support the stock in the short term despite broader economic uncertainties.

[1]